Kuypers KPC

Department of Neuropsychology & Psychopharmacology, Faculty of Psychology & Neuroscience, Maastricht University, Maastricht, The Netherlands. k.kuypers@maastrichtuniversity.nl.

37 papers · 1 preprint · ORCID

ArticlePsilocybin

Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.

Kuypers KPC, Mason NL, Carlier A +2

Europe PMC2026
ArticlePsychedelics

Molecules, meaning, and physiology: disentangling the active ingredients of psychedelic therapeutics.

Kuypers KPC

Europe PMC2026
ArticleLSD

Effects of repeated low-dose LSD on neuropsychological functioning in adults with ADHD: a randomized placebo-controlled study.

Haijen-Bongers ECHM, Hurks PPM, Schepers J +6

Europe PMC2026
ArticleMDMA

Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use.

Ramaekers JG, Kuypers KPC, Vollenweider FX

Europe PMC2026
ArticleLSD

A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers.

Cavarra M, Hutten NRPW, Schepers J +7

Europe PMC2025
ArticlePsilocybin

Between enhancement and risk: A critical review of psychedelic microdosing.

Totomanova I, Haijen ECHM, Hurks PPM +2

Europe PMC2025
ArticleLSD

Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.

Mueller L, Santos de Jesus J, Schmid Y +9

Europe PMC2025
ArticlePsilocybin

Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?

Totomanova I, Haijen ECHM, Hurks PPM +2

Europe PMC2025
ArticlePsilocybin

Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.

Destoop M, Mohr P, Butlen F +6

Europe PMC2025
ArticlePsychedelics

Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.

Ramaekers JG, Reckweg JT, Mason NL +3

Europe PMC2025
ArticleLSD

Inter-individual variability in neural response to low doses of LSD.

Hutten NRPW, Quaedflieg CWEM, Mason NL +7

Europe PMC2024
ArticlePsilocybin

Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions.

Tipado Z, Kuypers KPC, Sorger B +1

Europe PMC2024
ArticlePsychedelics

Effects of psychedelic microdosing versus conventional ADHD medication use on emotion regulation, empathy, and ADHD symptoms in adults with severe ADHD symptoms: A naturalistic prospective comparison study.

Haijen ECHM, Hurks PPM, Kuypers KPC

Europe PMC2024
ArticlePsychedelics

Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study.

Haijen ECHM, Hurks PPM, Kuypers KPC

Europe PMC2023
ArticlePsilocybin

Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.

Cavarra M, Mason NL, Kuypers KPC +5

Europe PMC2024
ArticlePsilocybin

Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition.

Mallaroni P, Mason NL, Reckweg JT +6

Europe PMC2023
ArticlePsychedelics

Microdosing with psychedelics to self-medicate for ADHD symptoms in adults: A prospective naturalistic study.

Haijen ECHM, Hurks PPM, Kuypers KPC

Europe PMC2022
ArticlePsilocybin

Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.

Kiraga MK, Kuypers KPC, Uthaug MV +2

Europe PMC2022
ArticlePsilocybin

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.

Rootman JM, Kiraga M, Kryskow P +5

Europe PMC2022
ArticlePsychedelics

Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions.

Cavarra M, Falzone A, Ramaekers JG +2

Europe PMC2022
PreprintPsilocybin

Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees

Kiraga M, Kuypers KPC, Uthaug MV +2

Europe PMC2022
ArticlePsilocybin

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.

Rootman JM, Kryskow P, Harvey K +6

Europe PMC2021
ArticleAyahuasca

Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being.

Kiraga MK, Mason NL, Uthaug MV +4

Europe PMC2021
ArticlePsilocybin

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.

de Vos CMH, Mason NL, Kuypers KPC

Europe PMC2021
ArticlePsilocybin

Spontaneous and deliberate creative cognition during and after psilocybin exposure.

Mason NL, Kuypers KPC, Reckweg JT +7

Europe PMC2021
ArticleAyahuasca

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.

Uthaug MV, Mason NL, Toennes SW +6

Europe PMC2021
ArticleLSD

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.

Holze F, Liechti ME, Hutten NRPW +7

Europe PMC2021
ArticleLSD

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.

Hutten NRPW, Mason NL, Dolder PC +6

Europe PMC2020
ArticleLSD

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.

Hutten NRPW, Mason NL, Dolder PC +8

Europe PMC2021
ArticlePsilocybin

The therapeutic potential of microdosing psychedelics in depression.

Kuypers KPC

Europe PMC2020
ArticlePsilocybin

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.

Mason NL, Kuypers KPC, Müller F +8

Europe PMC2020
ArticlePsilocybin

Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.

Heuschkel K, Kuypers KPC

Europe PMC2020
ArticlePsilocybin

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.

Hutten NRPW, Mason NL, Dolder PC +1

Europe PMC2019
ArticlePsilocybin

Motives and Side-Effects of Microdosing With Psychedelics Among Users.

Hutten NRPW, Mason NL, Dolder PC +1

Europe PMC2019
ArticleDMT

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.

Uthaug MV, Lancelotta R, van Oorsouw K +10

Europe PMC2019
ArticlePsilocybin

Psychedelic medicine: The biology underlying the persisting psychedelic effects.

Kuypers KPC

Europe PMC2019
ArticleAyahuasca

Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution.

Uthaug MV, van Oorsouw K, Kuypers KPC +6

Europe PMC2018
ArticleMDMA

MDMA-Induced Dissociative State not Mediated by the 5-HT<sub>2A</sub> Receptor.

Puxty DJ, Ramaekers JG, de la Torre R +4

Europe PMC2017